4//SEC Filing
Stromatt Scott C 4
Accession 0001019056-18-000439
CIK 0001671584other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 9:40 PM ET
Size
9.4 KB
Accession
0001019056-18-000439
Insider Transaction Report
Form 4
Stromatt Scott C
Chief Medical Officer and SVP
Transactions
- Exercise/Conversion
Restricted Stock Unit
2018-03-09−13,892→ 16,269 total→ Common Stock (13,892 underlying) - Exercise/Conversion
Common Stock
2018-03-09+13,892→ 204,737 total - Award
Employee Stock Options (Right to Buy)
2018-03-09+67,400→ 67,400 totalExercise: $3.13Exp: 2028-03-09→ Common Stock (67,400 underlying)
Footnotes (3)
- [F1]Each RSU converts into the Issuer's common stock on a one-for-one basis.
- [F2]On March 9, 2018, the reporting person was granted 67,400 stock options vesting in three equal annual installments beginning on the first anniversary of the grant date.
- [F3]The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 10, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, each RSU was adjusted and assumed by the Issuer. The RSUs fully vested as of March 9, 2018.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
Related Parties
1- filerCIK 0001679975
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 9:40 PM ET
- Size
- 9.4 KB